Regen BioPharma, Inc. (RGBP)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Sep 8, 2026, 3:02 PM EST
Regen BioPharma Market Cap
Regen BioPharma has a market cap or net worth of $1.68 thousand as of September 8, 2026. Its market cap has decreased by -99.77% in one year.
Market Cap
1.68K
Enterprise Value
908.68K
Revenue
236.56K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
ChartMarket Cap Chart
Since September 4, 2014, Regen BioPharma's market cap has decreased from 19.72M to 1.68K, a decrease of -99.99%. That is a compound annual growth rate of -54.16%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 1.68K | -99.79% |
| Dec 31, 2025 | 799.61K | -47.23% |
| Dec 31, 2024 | 1.52M | -57.47% |
| Dec 29, 2023 | 3.56M | -81.90% |
| Dec 30, 2022 | 19.69M | -70.55% |
| Dec 31, 2021 | 66.86M | 9,040.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Burzynski Research Institute | 262.90K |
| NKGen Biotech | 261.20K |
| Ampio Pharmaceuticals | 207.88K |
| Ocean Biomedical | 185.89K |
| Endonovo Therapeutics | 180.76K |
| THC Farmaceuticals | 163.18K |
| CNBX Pharmaceuticals | 160.58K |
| GB Sciences | 158.82K |